Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 16

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
657,058, respectively, shares to be issued whose issuance has been
deferred under the terms of employment and consulting agreements with officers and directors and other employees of Milestone Scientific.
Such shares will be issued to each party upon termination of their employment or other relationship with the Company. 

As
of September 30, 2025 and 2024, there were 631,792 and 527,625, respectively, shares to be issued to non-employees, that will
be issued to non-employees for services rendered. The number of shares was fixed by contract before the date of grant, subject to performance,
and were fully earned upon the grant date.

The
following table summarizes information about shares to be issued for the nine month periods ending September 30, 2025 and 2024.

 SCHEDULE
OF SHARES TO BE ISSUED

    September 30, 2025  
    September 30, 2024 

    Shares-to-be-issued, outstanding January 1, 2025 and 2024, respectively 
     3,393,017  
     3,098,917 
  
    Shares-to-be-issued, outstanding beginning balance 
     3,393,017  
     3,098,917 

    Granted in current period 
     315,646  
     438,868 
  
    Issued in current period 
     -  
     (353,102)
  
    Shares-to be issued outstanding September 30, 2025 and 2024, respectively 
     3,708,663  
     3,184,683 
  
    Shares-to be issued outstanding ending balance 
     3,708,663  
     3,184,683 

NOTE
8 — STOCK OPTION PLANS

Milestone
Scientific Inc., the Amended and Restated 2020 Equity Incentive Plan, provides for awards of restricted common, stock restricted stock
units, options to purchase and other awards. On June 28, 2023 the plan was amended and restated (the “2020 Plan”)
to increase the maximum shares that can be issued thereunder to 11,500,000 shares of common stock. The plan expires in June 2031.
Options may be granted to employees, directors, and consultants of Milestone Scientific for the purchase of shares of common stock at
a price